About: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.59 (-20.50%)
UPB NASDAQ Upstream Bio, Inc.
Upstream Bio, Inc. share price
Atividade de preço de UPB
Último preço
$ 1,590
Variação (24h)
-0,41 USD (20,50%)
Volume
1.39M
Volume (média 4 sem.)
-
Abertura
$ 1,98
Variação do dia
$ 1,56 - $ 2,06
Fechamento anterior
$ 2,00
Último negócio
20 Nov, 9:00 pm GMT+0
Atrasado
20 Nov, 9:00 pm GMT+0
UPB price performance
Atrasado
20 Nov, 9:00 pm GMT+0
UPB details
quote.marketSignals